8. Herpes zoster and post herpetic neuralgia
Pain Practice · 2025-01 · 25 (1)
DOI: 10.1111/papr.13423 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pain Practice, online erschienen am 04.10.2024. Verfasst von Elisabeth J M Adriaansen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pain Clinic, Department of Anesthesiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Patients suffering from postherpetic neuralgia (PHN) report unilateral chronic pain in one or more dermatomes after an acute herpes zoster (HZ) infection. The incidence of acute HZ ranges between three and five patients per 1000 person‐years. In one out of four patients, acute HZ‐related pain will transition into PHN. PHN can be very disabling for patients and reduce quality of life. Additionally, the treatment of PHN is characterized by high failure rates. The aim of this review is to give an update on the previous practical guideline published in 2011 and revised in 2015 (published in 2019) and to provide an overview of current interventional treatment options for HZ infection and PHN.
Methods
The literature on the diagnosis and treatment of HZ and PHN was systematically reviewed and summarized.
Results
The most important treatment for acute HZ‐related pain is antiviral therapy within 72 h of symptom onset. Additional symptomatic treatment options are analgesic drugs according to the WHO pain ladder, tricyclic antidepressants (eg, nortriptyline), and antiepileptic drugs (eg, gabapentin). If pain is not sufficiently reduced, interventional treatment such as an epidural injection with local anesthetics and corticosteroids or pulsed radiofrequency of the dorsal root ganglion (DRG) are options. Treatment for PHN is preferably transdermal capsaicin, lidocaine, or oral drugs such as antidepressants or antiepileptics.
Conclusions
Treatment of acute HZ‐related pain especially PHN is challenging. Besides the conventional treatment for PHN, interventional management is considered a new treatment option. PRF of DRG seems to be the most promising interventional management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pain Clinic, Department of Anesthesiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
- Anesthesiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
- Department of Anesthesiology, Intensive Care and Pain Medicine, St. Antonius Hospital, Nieuwegein, The Netherlands.
- Anesthesiology, Neurology, Physical Medicine & Rehabilitation and Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- Anesthesiology and Physical Medicine & Rehabilitation, Walter Reed National Military Medical Center, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
- Pain Clinic, Department of Anesthesiology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands.
ORCID-Profile: Elisabeth J M Adriaansen
Zitieren
APA
Adriaansen, E. J. M., Jacobs, J. G., Vernooij, L. M., van Wijck, A. J. M., Cohen, S. P., Huygen, F. J. P. M., & Rijsdijk, M. (2025). 8. Herpes zoster and post herpetic neuralgia. Pain Practice, 25(1). https://doi.org/10.1111/papr.13423
Vancouver
Adriaansen EJM, Jacobs JG, Vernooij LM, van Wijck AJM, Cohen SP, Huygen FJPM, et al. 8. Herpes zoster and post herpetic neuralgia. Pain Practice. 2025;25(1). doi:10.1111/papr.13423
BibTeX
@article{Adriaansen2025,
author = {Adriaansen, Elisabeth J M and Jacobs, Julien G and Vernooij, Lisette M and van Wijck, Albert J M and Cohen, Steven P and Huygen, Frank J P M and Rijsdijk, Mienke},
title = {8. Herpes zoster and post herpetic neuralgia},
journal = {Pain Practice},
year = {2025},
volume = {25},
number = {1},
doi = {10.1111/papr.13423}
}
EUVIMED